Recent advances in non-small cell lung cancer targeted therapy; an update review

M Araghi, R Mannani, A Heidarnejad maleki… - Cancer cell …, 2023 - Springer
Lung cancer continues to be the leading cause of cancer-related death worldwide. In the last
decade, significant advancements in the diagnosis and treatment of lung cancer, particularly …

Squamous cell lung cancer: Current landscape and future therapeutic options

SCM Lau, Y Pan, V Velcheti, KK Wong - Cancer Cell, 2022 - cell.com
Squamous cell lung cancers (lung squamous cell carcinomas [LUSCs]) are associated with
high mortality and a lack of therapies specific to this disease. Although recurrent molecular …

[HTML][HTML] Web-based survival analysis tool tailored for medical research (KMplot): development and implementation

A Lánczky, B Győrffy - Journal of medical Internet research, 2021 - jmir.org
Background Survival analysis is a cornerstone of medical research, enabling the
assessment of clinical outcomes for disease progression and treatment efficiency. Despite …

Non–small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology

DS Ettinger, DE Wood, DL Aisner, W Akerley… - Journal of the National …, 2022 - jnccn.org
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell
Lung Cancer (NSCLC) provide recommended management for patients with NSCLC …

[HTML][HTML] Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

D Planchard, ST Popat, K Kerr, S Novello, EF Smit… - Annals of …, 2018 - Elsevier
Primary lung cancer remains the most common malignancy after non-melanocytic skin
cancer, and deaths from lung cancer exceed those from any other malignancy worldwide [1] …

Non–small cell lung cancer: epidemiology, screening, diagnosis, and treatment

N Duma, R Santana-Davila, JR Molina - Mayo Clinic Proceedings, 2019 - Elsevier
Lung cancer remains the leading cause of cancer deaths in the United States. In the past
decade, significant advances have been made in the science of non–small cell lung cancer …

[HTML][HTML] Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

S Novello, F Barlesi, R Califano, T Cufer, S Ekman… - Annals of …, 2016 - Elsevier
In 2012, lung cancer was the most frequently diagnosed cancer and the leading cause of
cancer death in male populations. Among females, lung cancer was the leading cause of …

Mechanisms of receptor tyrosine kinase activation in cancer

Z Du, CM Lovly - Molecular cancer, 2018 - Springer
Receptor tyrosine kinases (RTKs) play an important role in a variety of cellular processes
including growth, motility, differentiation, and metabolism. As such, dysregulation of RTK …

[HTML][HTML] Correction to:“Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”

D Planchard, S Popat, K Kerr, S Novello, EF Smit… - Annals of …, 2019 - Elsevier
1. In KEYNOTE-189, patients with metastatic non-squamous NSCLC, PS 0-1, without
sensitising EGFR or ALK mutations, were randomised to receive pemetrexed and a platinum …

The potential of radiomic-based phenoty** in precision medicine: a review

HJWL Aerts - JAMA oncology, 2016 - jamanetwork.com
Importance Advances in genomics have led to the recognition that tumors are populated by
distinct genotypic subgroups that drive tumor development and progression. The spatial and …